Erasca ERAS
NASDAQ ERAS
$15.49 -0.11 (-0.74%)
As of: Nov 10, 2026 · 3:52 PM EST

Erasca (ERAS) EBITDA Margin (2020 - 2026)

Updated

Analysis

Erasca (ERAS) EBITDA Margin (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 54.65%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 32.68%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 46.88%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 40.75%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 46.62%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 50.63%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 42.49%
10 Erasca 4.82 Bn 3.74 Bn - -1,301.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,301.78%
Mar 31, 2026 -4,207.42%
Dec 31, 2025 -894.48%
Sep 30, 2025 -850.94%
Jun 30, 2025 -862.31%
Mar 31, 2025 -734.35%
Dec 31, 2024 -660.74%
Sep 30, 2024 -620.21%
Jun 30, 2024 -1,322.79%
Mar 31, 2024 -970.59%
Dec 31, 2023 -777.25%
Sep 30, 2023 -775.82%
Jun 30, 2023 -823.69%
Mar 31, 2023 -931.93%
Dec 31, 2022 -4,765.29%
Sep 30, 2022 -2,377.86%
Jun 30, 2022 -9,116.24%
Mar 31, 2022 -31,668.42%
Dec 31, 2021 -38,410.00%
Sep 30, 2021 -93,577.55%
API Access

Erasca EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ERAS&period=max&api_key=YOUR_API_KEY